Literature DB >> 7492773

On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing blood.

S C Endenburg1, R R Hantgan, L Lindeboom-Blokzijl, H Lankhof, W G Jerome, J C Lewis, J J Sixma, P G de Groot.   

Abstract

Platelet adhesion to fibrin at high shear rates depends on both the glycoprotein (GP) IIb:IIIa complex and a secondary interaction between GPIb and von Willebrand factor (vWF). This alternative link between platelets and vWF in promoting platelet adhesion to fibrin has been examined in flowing whole blood with a rectangular perfusion chamber. Optimal adhesion required both platelets and vWF, as shown by the following observations. No binding of vWF could be detected when plasma was perfused over a fibrin surface or when coated fibrinogen was incubated with control plasma in an enzyme-linked immunosorbent assay. However, when platelets were present during perfusion, interactions between vWF and fibrin could be visualized with immunoelectron microscopy. Exposure of fibrin surfaces to normal plasma before perfusion with severe von Willebrand's disease blood did not compensate for the presence of plasma vWF necessary for adhesion. vWF mutants in which the GPIIb:IIIa binding site was mutated or the GPIb binding site was deleted showed that vWF only interacts with GPIb on platelets in supporting adhesion to fibrin and not with GPIIb:IIIa. Complementary results were obtained with specific monoclonal antibodies against vWF. Thus, vWF must first bind to platelets before it can interact with fibrin and promote platelet adhesion. Furthermore, only GPIb, but not GPIIb:IIIa is directly involved in this interaction of vWF with platelets.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492773

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow.

Authors:  Judith M E M Cosemans; Saskia E M Schols; Lucia Stefanini; Susanne de Witt; Marion A H Feijge; Karly Hamulyák; Hans Deckmyn; Wolfgang Bergmeier; Johan W M Heemskerk
Journal:  Blood       Date:  2010-10-29       Impact factor: 22.113

2.  Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network.

Authors:  Adam Miszta; Leonie Pelkmans; Theo Lindhout; Ganeshram Krishnamoorthy; Philip G de Groot; Coenraad H Hemker; Johan W M Heemskerk; Hilde Kelchtermans; Bas de Laat
Journal:  J Biol Chem       Date:  2014-11-07       Impact factor: 5.157

3.  N-terminal flanking region of A1 domain in von Willebrand factor stabilizes structure of A1A2A3 complex and modulates platelet activation under shear stress.

Authors:  Matthew Auton; Katie E Sowa; Molly Behymer; Miguel A Cruz
Journal:  J Biol Chem       Date:  2012-03-19       Impact factor: 5.157

4.  A recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemia.

Authors:  Trung C Nguyen; Francisca Gushiken; Juliana I Correa; Jing-Fei Dong; Swapan K Dasgupta; Perumal Thiagarajan; Miguel A Cruz
Journal:  Thromb Res       Date:  2015-03-03       Impact factor: 3.944

5.  Free hemoglobin increases von Willebrand factor-mediated platelet adhesion in vitro: implications for circulatory devices.

Authors:  Qi Da; Miho Teruya; Prasenjit Guchhait; Jun Teruya; John S Olson; Miguel A Cruz
Journal:  Blood       Date:  2015-08-25       Impact factor: 22.113

6.  Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stress.

Authors:  Matthew Auton; Katie E Sowa; Scott M Smith; Erik Sedlák; K Vinod Vijayan; Miguel A Cruz
Journal:  J Biol Chem       Date:  2010-05-24       Impact factor: 5.157

7.  Kinetics of platelet adhesion to a fibrinogen-coated surface in whole blood under flow conditions.

Authors:  Zufar A Gabbasov; Yuliya N Avtaeva; Ivan S Melnikov; Sergey D Okhota; Martin Caprnda; Ioana Mozos; Robert Prosecky; Luis Rodrigo; Peter Kruzliak; Nadezhda I Zozulya
Journal:  J Clin Lab Anal       Date:  2021-08-04       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.